1. Home
  2. AVIR
  3. AVIR News

Latest Atea Pharmaceuticals Inc. (AVIR) News on July 27, 2024

Atea Pharmaceuticals Presents Positive Initial Phase 2 Data for Bemnifosbuvir and Ruzasvir Combination for Treatment of Hepatitis C Virus at EASL Congress 2024
AVIR

GlobeNewswire

2 months ago

Atea Pharmaceuticals Presents Positive Initial Phase 2 Data for Bemnifosbuvir and Ruzasvir Combination for Treatment of Hepatitis C Virus at EASL Congress 2024

Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
AVIR

GlobeNewswire

2 months ago

Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference

Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024
AVIR

GlobeNewswire

2 months ago

Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024

AVIR

GuruFocus.com

2 months ago

Atea Pharmaceuticals Inc (AVIR) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...

Atea Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
AVIR

GlobeNewswire

2 months ago

Atea Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024
AVIR

GlobeNewswire

3 months ago

Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024

Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
AVIR

GlobeNewswire

3 months ago

Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024

Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
AVIR

GlobeNewswire

4 months ago

Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript
AVIR

Insider Monkey

5 months ago

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript

AVIR

GuruFocus.com

5 months ago

Atea Pharmaceuticals Inc (AVIR) Announces Q4 and Full Year 2023 Financial Results

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AVIR

GlobeNewswire

5 months ago

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
AVIR

GlobeNewswire

5 months ago

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

Investors in York Water (NASDAQ:YORW) have unfortunately lost 15% over the last three years
AVIR

Simply Wall St.

6 months ago

Investors in York Water (NASDAQ:YORW) have unfortunately lost 15% over the last three years

Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024
AVIR

GlobeNewswire

6 months ago

Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024

Q3 Earnings Outperformers: Zeta (NYSE:ZETA) And The Rest Of The Advertising Software Stocks
AVIR

StockStory

6 months ago

Q3 Earnings Outperformers: Zeta (NYSE:ZETA) And The Rest Of The Advertising Software Stocks

Advertising Software Stocks Q3 Earnings: AppLovin (NASDAQ:APP) Best of the Bunch
AVIR

StockStory

6 months ago

Advertising Software Stocks Q3 Earnings: AppLovin (NASDAQ:APP) Best of the Bunch

Atea Pharma (AVIR) Gains on Upbeat Initial Data From HCV Study
AVIR

Zacks

7 months ago

Atea Pharma (AVIR) Gains on Upbeat Initial Data From HCV Study

Atea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19
AVIR

GlobeNewswire

7 months ago

Atea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19

AVIR

Business Wire

7 months ago

DTS AutoStage™ Expands into More Vehicle Models Following Video Launch, Developing New Functionality

AVIR

Business Wire

7 months ago

Xperi Expands its Global Footprint with its Powered by TiVo Media Platform for Smart TVs and Connected Car

How Diversified Energy blazed a trail for energy companies
AVIR

Yahoo Finance Video

7 months ago

How Diversified Energy blazed a trail for energy companies

Is It Time To Consider Buying LSB Industries, Inc. (NYSE:LXU)?
AVIR

Simply Wall St.

7 months ago

Is It Time To Consider Buying LSB Industries, Inc. (NYSE:LXU)?

Why Renewable Energy Stocks Plunged on Wednesday
AVIR

Motley Fool

7 months ago

Why Renewable Energy Stocks Plunged on Wednesday

TEGNA and NBC Renew Affiliation Agreement
AVIR

Business Wire

7 months ago

TEGNA and NBC Renew Affiliation Agreement

Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
AVIR

GlobeNewswire

7 months ago

Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock
AVIR

GlobeNewswire

7 months ago

Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
AVIR

GlobeNewswire

7 months ago

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

Safe Bulkers, Inc.'s (NYSE:SB) top owners are individual investors with 37% stake, while 26% is held by insiders
AVIR

Simply Wall St.

7 months ago

Safe Bulkers, Inc.'s (NYSE:SB) top owners are individual investors with 37% stake, while 26% is held by insiders

The Zacks Analyst Blog Highlights Assurant, Kinsale Capital Group and NMI Holdings
AVIR

Zacks

7 months ago

The Zacks Analyst Blog Highlights Assurant, Kinsale Capital Group and NMI Holdings

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools
AVIR

PR Newswire

7 months ago

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools

Will Garmin Ltd. (GRMN) Face Stiffer Competition?
AVIR

Insider Monkey

7 months ago

Will Garmin Ltd. (GRMN) Face Stiffer Competition?

Modernize Unveils In-Depth Homeowner Insights Report: A Guide to Future-Proofing Your Business
AVIR

Business Wire

7 months ago

Modernize Unveils In-Depth Homeowner Insights Report: A Guide to Future-Proofing Your Business

AVIR

Investing.com

7 months ago

Macy's shares jump 20% on $5.8 billion buyout offer: 4 big deal reports

Duff & Phelps Utility and Infrastructure Fund Inc. Announces Dividend and Discloses Sources of Distribution Section 19(a) Notice
AVIR

Business Wire

7 months ago

Duff & Phelps Utility and Infrastructure Fund Inc. Announces Dividend and Discloses Sources of Distribution Section 19(a) Notice

There's A Lot To Like About Ituran Location and Control's (NASDAQ:ITRN) Upcoming US$0.24 Dividend
AVIR

Simply Wall St.

7 months ago

There's A Lot To Like About Ituran Location and Control's (NASDAQ:ITRN) Upcoming US$0.24 Dividend

Icosavax, Inc. (ICVX) Is Up 0.10% in One Week: What You Should Know
AVIR

Zacks

7 months ago

Icosavax, Inc. (ICVX) Is Up 0.10% in One Week: What You Should Know

Why Eagle Bulk Shipping Stock Just Popped 12%
AVIR

Motley Fool

7 months ago

Why Eagle Bulk Shipping Stock Just Popped 12%

Liquidity Services, Inc. (NASDAQ:LQDT) Q4 2023 Earnings Call Transcript
AVIR

Insider Monkey

8 months ago

Liquidity Services, Inc. (NASDAQ:LQDT) Q4 2023 Earnings Call Transcript

SilverBow Resources Announces Closing of Chesapeake Acquisition and Provides Updated 2023 Guidance & Preliminary 2024 Outlook
AVIR

Business Wire

8 months ago

SilverBow Resources Announces Closing of Chesapeake Acquisition and Provides Updated 2023 Guidance & Preliminary 2024 Outlook

5 Things to Know Before Markets Open
AVIR

Investopedia

8 months ago

5 Things to Know Before Markets Open

Do Options Traders Know Something About TETRA Technologies (TTI) Stock We Don't?
AVIR

Zacks

8 months ago

Do Options Traders Know Something About TETRA Technologies (TTI) Stock We Don't?

77 Percent of Consumers Plan to Participate in the 2023 Holiday Shopping Season
AVIR

PR Newswire

8 months ago

77 Percent of Consumers Plan to Participate in the 2023 Holiday Shopping Season

Insider Sell Alert: Director Mark Folse Sells 25,000 Shares of Business First Bancshares Inc (BFST)
AVIR

GuruFocus.com

8 months ago

Insider Sell Alert: Director Mark Folse Sells 25,000 Shares of Business First Bancshares Inc (BFST)

AVIR

Thomson Reuters StreetEvents

8 months ago

Q4 2023 Oaktree Specialty Lending Corp Earnings Call

MicroVision Directors and Executive Team to Purchase Shares
AVIR

ACCESSWIRE

8 months ago

MicroVision Directors and Executive Team to Purchase Shares

HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade
AVIR

Zacks

8 months ago

HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade

Oaktree Specialty Lending (OCSL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
AVIR

Zacks

8 months ago

Oaktree Specialty Lending (OCSL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Atea Pharmaceuticals Presents Promising Bemnifosbuvir and Ruzasvir Combination Data for the Treatment of Hepatitis C Virus at AASLD The Liver Meeting 2023
AVIR

GlobeNewswire

8 months ago

Atea Pharmaceuticals Presents Promising Bemnifosbuvir and Ruzasvir Combination Data for the Treatment of Hepatitis C Virus at AASLD The Liver Meeting 2023

AVIR

Thomson Reuters StreetEvents

9 months ago

Q3 2023 BlackRock Capital Investment Corp Earnings Call

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript
AVIR

Insider Monkey

9 months ago

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript

AVIR

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Atea Pharmaceuticals Inc Earnings Call

Mativ Holdings Inc (MATV) Faces Headwinds in Q3 2023 Amid Goodwill Impairment Charge
AVIR

GuruFocus.com

9 months ago

Mativ Holdings Inc (MATV) Faces Headwinds in Q3 2023 Amid Goodwill Impairment Charge

Atea Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
AVIR

GlobeNewswire

9 months ago

Atea Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Atea Pharmaceuticals Announces Participation at Upcoming Investor Conferences
AVIR

GlobeNewswire

9 months ago

Atea Pharmaceuticals Announces Participation at Upcoming Investor Conferences

AN2 Therapeutics, Inc. (ANTX) Is a Great Choice for 'Trend' Investors, Here's Why
AVIR

Zacks

9 months ago

AN2 Therapeutics, Inc. (ANTX) Is a Great Choice for 'Trend' Investors, Here's Why

AN2 Therapeutics to Present at Upcoming Investor Conferences
AVIR

Business Wire

9 months ago

AN2 Therapeutics to Present at Upcoming Investor Conferences

Share on Social Networks: